Cargando…

Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact

Detalles Bibliográficos
Autores principales:	Russo, Vincenzo, Silverio, Angelo, Scudiero, Fernando, Micco, Pierpaolo Di, Di Maio, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972716/ https://www.ncbi.nlm.nih.gov/pubmed/33810938 http://dx.doi.org/10.1016/j.ejim.2021.03.017

Ejemplares similares

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation
por: Russo, Vincenzo, et al.
Publicado: (2022)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Addressing the Challenge of Atrial Fibrillation Management: How to Differentiate the Approach Depending on Left Ventricular Ejection Fraction
por: De Vecchis, Renato, et al.
Publicado: (2019)

Prevalence of atrial fibrillation in Thai elderly
por: Phrommintikul, Arintaya, et al.
Publicado: (2016)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Atrial Fibrillation is A Predictor of Drug-Related Bradycardia and Hospital Admission in Older Adults
por: Griffiths, Charlotte, et al.
Publicado: (2021)

Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Long-Term Prognostic Impact of Right Ventricular Dysfunction in Patients with COVID-19
por: Scudiero, Fernando, et al.
Publicado: (2022)

Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
por: Rago, Anna, et al.
Publicado: (2023)

The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19
por: Agarwal, Siddharth, et al.
Publicado: (2023)

Perioperative predictors of atrial fibrillation
por: İşcan, Şahin, et al.
Publicado: (2018)

Mercury overexposure and atrial fibrillation
por: Guzzi, Gianpaolo, et al.
Publicado: (2016)

New‐onset atrial fibrillation after atrial ischemia
por: Kondo, Yusuke, et al.
Publicado: (2019)

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023)

Impact of Aerobic Interval Training on the Endothelial Function in Patients with Atrial Fibrillation
por: Doi, Yuki, et al.
Publicado: (2023)

Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure
por: Kalmar, Alain F, et al.
Publicado: (2023)

Risk of Atrial Fibrillation in Pemphigus Vulgaris
por: Namazi, Nastaran, et al.
Publicado: (2018)

Atrial fibrillation after cardiac surgery
por: İşcan, Şahin, et al.
Publicado: (2015)

Usefulness of left atrial speckle-tracking echocardiography in patients with atrial fibrillation
por: Mares, Razvan Gheorghita, et al.
Publicado: (2017)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Secondary Prevention of Atrial Fibrillation: Is It Worth Doing?
por: De Vecchis, Renato
Publicado: (2019)

Atrial fibrillation – QT interval and catheter ablation
por: Mann, Linda, et al.
Publicado: (2020)

Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease”
por: Güzel, Tuncay, et al.
Publicado: (2023)

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Antioxidant Therapy for Atrial Fibrillation: What Is the Next Step?
por: Sovari, Ali A.
Publicado: (2011)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
por: Champion, Sébastien
Publicado: (2015)

Catatonic depression precipitated by amiodarone prescribed for atrial fibrillation
por: Rajagopal, Sundararajan
Publicado: (2015)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
por: Jelliffe, Roger
Publicado: (2016)

Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients
por: Cerit, Levent
Publicado: (2016)

Persistent ductus arteriosus in old patient with atrial fibrillation
por: Rajewska-Tabor, Justyna, et al.
Publicado: (2018)

Effects of cardiopulmonary bypass on new-onset atrial fibrillation
por: Gökalp, Orhan, et al.
Publicado: (2016)

Postoperative atrial fibrillation may be associated with other factors
por: Akyüz, Ali Rıza, et al.
Publicado: (2016)

Atrial fibrillation and cancer: Two peas in a pod
por: Leiva, Orly
Publicado: (2023)

Right Hemispheric Predominance of Brain Infarcts in Atrial Fibrillation: A Lesion Mapping Analysis
por: Altermatt, Anna, et al.
Publicado: (2022)

Atrial fibrillation recurrence post pulmonary vein isolation: The complex secrets of left atrial geometry
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2022)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Cigarette smoking and COVID-19
por: Rossato, Marco, et al.
Publicado: (2021)

Smoking history and clinical outcomes in COVID-19 hospitalized patients
por: Rossato, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ocitst6a5iefhgakgtjqghf6tr